27 Dec, EOD - Indian

SENSEX 78699.07 (0.29)

Nifty 50 23813.4 (0.27)

Nifty Bank 51311.3 (0.27)

Nifty IT 43721.4 (0.13)

Nifty Midcap 100 56979.8 (-0.26)

Nifty Next 50 68557.15 (-0.88)

Nifty Pharma 23008.35 (1.30)

Nifty Smallcap 100 18755.85 (0.15)

27 Dec, EOD - Global

NIKKEI 225 40281.16 (1.80)

HANG SENG 20090.46 (-0.04)

S&P 6041.25 (-1.08)

Login/Signup
LOGIN HERE
Cancel

Amrutanjan Health Care Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 590006 | NSE Symbol : AMRUTANJAN | ISIN : INE098F01031 | Industry : Pharmaceuticals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
04-Nov-2024 12-Nov-2024 Quarterly Results AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve the Un-audited Financial Results along with the Limited Review Report for the Quarter Ended 30th September 2024 and Declaration of 1st Interim Dividend for the Financial Year 2024-25 Outcome of Board Meeting held on November 12, 2024 (As per BSE Announcement Dated on 11/11/2024)
05-Aug-2024 13-Aug-2024 Quarterly Results AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Board Meeting Intimation u/r 29(1) of SEBI (LODR) Regulations 2015. Outcome of the Board Meeting (As Per BSE Announcement Dated on: 13/08/2024)
14-May-2024 23-May-2024 Final Dividend AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve i) Audited Financial Results along with Independent Auditors Report for year ended 31.03.2024 ii) Recommendation of Final dividend for the FY 2023-24 Financial Results for the year ended 31.03.2024 Financial Result Intimation on Grant of Stock Options under Amrutanjan Health Care Limited Employee Stock Option Scheme 2020 (As per BSE Announcement Dated on 23/05/2024)
01-Feb-2024 09-Feb-2024 Quarterly Results AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Board Meeting prior intimation under Reg. 29 of SEBI (LODR) Inter alia, declared Second Interim Dividend of Re.1/- per share for the financial year 2023- 24 on the Equity Shares of the Company Outcome of Board Meeting Financial result (As Per BSE Announcement Dated on 09.02.2024)
02-Nov-2023 10-Nov-2023 Quarterly Results AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve Board Meeting Intimation for Considering And Approving inter-alia the Unaudited Financial Results For The Quarter/Half Year Ended 30th September 2023 and declaration of 1st Interim Dividend for the financial year 2023-24. Board approved: (i) Declared First Interim Dividend of Re.1/- per share for the financial year 2023-24 on the Equity Shares of the Company. (ii) Recommended Re-Appointment of Mr. S. Sambhu Prasad as Chairman and Managing Director of the Company for a further period of five years from 01-04-2024 to 31-03-2029 which is subject to approval of the Shareholders through Postal Ballot. Outcome of the Board Meeting held on 10-11-2023 Outcome of the Board meeting held on November 10, 2023 approving the unaudited financial results for the quarter/half year ended 30th September 2023 and declaration of First Interim Dividend for the FY 2023-24 Amrutanjan Health Care Limited has fixed 23-11-2023 as record date for the purpose of payment of first interim dividend for FY 2023-24 Amrutanjan Health Care Limited has fixed 23-11-2023 as the record date for the purpose of payment of First Interim Dividend for FY 2023-24 (As Per BSE Announcement Dated on 10.11.2023) AMRUTANJAN HEALTH CARE LIMITED has informed BSE regarding Outcome of Board Meeting held on 11 Oct 2023 for Dividend. (As Per BSE Announcement Dated on 11.11.2023)
26-Jul-2023 02-Aug-2023 Quarterly Results AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2023 inter alia to consider and approve Un-Audited Financial Results along with the Limited Review Report for the quarter ended June 30 2023. Pursuant to the subject regulation(s), we wish to inform that the Board of Directors of the Company at its meeting held today (August 2, 2023) had inter-alia approved - The Unaudited Financial Results for the quarter ended June 30, 2023 as recommended by the Audit Committee at its meeting held today (August 2, 2023). The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company, is enclosed. We wish to inform that the Board of Directors of the Company at its meeting held today (August 2, 2023) had inter- alia approved the unaudited financial results for the quarter ended June 30, 2023. The same along with the Limited Review Report issued by M/s. BSR & Co. LLP, Statutory auditors of the company is enclosed We wish to inform you that the Board of Directors of the Company at their meeting held today (Aug 2 2023) had inter-alia approved: That the Share transfer register shall be closed from Friday, September 15, 2023 to Thursday, September 21 2023 (both days inclusive) (As Per BSE Announcement dated on 02.08.2023)
26-Jun-2023 30-Jun-2023 Buy Back AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2023 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of Amrutanjan Health Care Limited (Company) will be held on Friday June 30 2023 inter alia (a) to consider the proposal to appoint a director to fill the casual vacancy caused by the death of Dr. P.S.N. Murthi Non-Executive Non-Independent Director; and (b) to consider a proposal for buyback of fully paid-up equity shares of the Company of face value of ? 1/- each as well as matters related/incidental thereto in accordance with the applicable provisions under the Companies Act 2013 (including the rules and regulations framed thereunder) the Securities and Exchange Board of India (Buy-back of Securities) Regulations 2018 as amended and other applicable laws. 1. Approved the proposal for buyback of fully paid-up equity shares of the Company of face value of ? 1/- each as well as matters related/incidental thereto, in accordance with the applicable provisions under the Companies Act, 2013 (including the rules and regulations framed thereunder), the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended, and other applicable laws as per outcome attached. 2. Approved the appointment of Non-executive non independent director to fill the casual vacancy caused by the death of Dr. P.S.N. Murthi, Non-Executive Non-Independent Director. The board of directors of the Company have approved the Buyback by passing a resolution on Friday, June 30, 2023. Kindly refer to our letter no. AHCL/SE/16/2023-24 dated June 30, 2023 intimating the outcome of the Board meeting. Please find enclosed copy of the board resolution passed by the board members pursuant to Regulation 5(vii) of the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018 , as amended The Board of Directors of the company at its Board Meeting held today (June 30, 2023) has inter-alia considered and approved appointment of Ms. Ramaa Prabhakar Arikirevula (DIN 09465903) as the Non- Executive Non- Independent Director of the Company effective from 30th June 2023 to fill the casual vacancy caused by the death of Dr. P.S.N. Murthi. Ms. Ramaa Prabhakar shall hold office until the conclusion of the 86th Annual General Meeting of the Company (As Per BSE Announcement Dated on 30.06.2023) Amrutanjan Health Care Limited has informed BSE regarding Outcome of Board Meeting held on 30 Jun 2023 for Buy-back. (As Per BSE Announcement Dated on 01.07.2023)
19-May-2023 30-May-2023 Accounts AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 inter alia to consider and approve (i) Audited Financial Results along with the Audit Report by the Statutory Auditors for the quarter and year ended March 31 2023. (ii) Declaration of Final Dividend for the financial year 2022-23; if any The Board Meeting to be held on 27/05/2023 has been revised to 30/05/2023 Please refer to our earlier intimation about Board Meeting scheduled on 27th May 2023. we wish to inform that the said meeting of the Board of Directors is re-scheduled and will now be held on Tuesday, the 30th May, 2023 thru Video Conferencing (As per BSE Announcement Dated on 23/05/2023)
07-Feb-2023 14-Feb-2023 Quarterly Results AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Pursuant to the above mentioned regulation of SEBI LODR we wish to inform that a meeting of the Board of Directors is scheduled to be held on Tuesday the 14th February 2023 thru Video Conferencing to consider and approve inter-alia the: a) Un-Audited Financial Results along with the Limited Review Report for the quarter ended December 31 2022. b) Declaration of 2nd Interim Dividend for the financial year 2022-23 Request to take the above on record and acknowledge. In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (February 14, 2023) had inter-alia: (i) Approved the Un-Audited Financial Results for the quarter ended December 31, 2022. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Declared Second Interim Dividend of Re.1/- per share for the financial year 2022-23 on the Equity Shares of the Company. (As Per BSE Announcement Dated on 14.02.2023)
27-Oct-2022 04-Nov-2022 Quarterly Results AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2022 inter alia to consider and approve we wish to inform that a meeting of the Board of Directors is scheduled to be held on Friday the 04th November 2022 to consider and approve inter-alia the: a) Un-Audited Financial Results along with the Limited Review Report for the quarter and half year ended September 30 2022. b) Declaration of 1st Interim Dividend for the financial year 2022-23 In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (November 04, 2022) had inter-alia: (i) Approved the Un-audited Financial Results for the quarter and half year ended September 30, 2022. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Declared First Interim Dividend of Re.1/- per share for the financial year 2022-23 on the Equity Shares of the Company. Approved the Un-audited Financial Results for the quarter and half year ended September 30, 2022. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed (As Per BSE Announcement dated 04.11.2022)
04-Aug-2022 12-Aug-2022 Quarterly Results AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve Pursuant to the above mentioned regulation of SEBI LODR we wish to inform that a meeting of the Board of Directors is scheduled to be held on Friday the 12th August 2022 thru Video Conferencing to consider and approve inter-alia the Un-Audited Financial Results along with the Limited Review Report for the quarter ended June 30 2022. It may also be noted that as already informed vide our letter dt. 29th June 2022 the Trading window for dealing in equity shares of the Company is closed effective from 1st July 2022 and will remain closed till 14th August 2022 pursuant to SEBI (PIT) Regulations 2015 and in terms of Code of Conduct to regulate monitor and report trading in securities of the Company. Request you to take the above on record and acknowledge. Pursuant to the subject regulation(s), we wish to inform that the Board of Directors of the Company at its meeting held today (August 12, 2022) had inter-alia approved the The Unaudited Financial Results for the quarter ended June 30, 2022 as recommended by the Audit Committee at its meeting held today (August 12, 2022). The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company, is enclosed. Approved appointment of Ms. Meenalochani Raghunathan (DIN: 07145001) as an Additional Director (Non-Executive Independent) on the Board of the Company with effect from 12.08.2022 We wish to inform you that the Board of Directors of the Company at their meeting held today (Aug 12 2022) had inter-alia approved: a. Holding the Eighty Fifth (85th ) Annual General Meeting (AGM) of the Company on September 22, 2022 (Thursday) at 10.30A.M through Video Conference ('VC')/ Other Audio Visual Means ('OAVM') b. Thursday September 15, 2022 as the cut-off/Record date for the purpose of determining the eligibility criteria of shareholders to receive Final Dividend 2021-22 and to attend /vote at the Annual General Meeting to be held on September 22, 2022 c. The Book closure shall be from Friday, September 16, 2022 to Thursday, September 22, 2022 (both days inclusive) The Board of Directors at their meeting held today (August 12 2022) had inter alia considered and approved the following proposals 1. Re-appointment of Dr. Pasumarthi SN Murthi Non-Executive Director retiring my rotation subject to the approval of Shareholders. 2. Retirement of Dr. Mr. S. Vydeeswaran and Dr. Ms. Marie Shiranee Pereira Non-Executive Independent Directors of the Company at the ensuing Annual General Meeting. 3. Appointment of Ms. Meenalochani Raghunathan (DIN: 07145001) as an Additional Director (Non-Executive Independent) on the Board of the Company w.e.f 12.08.2022 subject to approval of shareholder in the 85th AGM. we further inform and declare that pursuant to Circular LIST/COMP /14/2018-19 dated June 20, 2018 . Ms. Meenalochani Raghunathan (DIN: 07145001) is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority (As per BSE Announcement Dated on 12/08/2022)
17-May-2022 24-May-2022 Accounts AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 inter alia to consider and approve Pursuant to the above mentioned regulation of SEBI LODR we wish to inform that a meeting of the Board of Directors is scheduled to be held on Tuesday the 24th May2022 thru video Conferencing to consider and approve inter-alia (i) Audited Financial Results along with the Audit Report by the statutory Auditors for the quarter and year ended March 3I 2022. (ii)Declaration of Final Dividend for the financial year 2021-22; if any It may also be noted that as already informed vide our letter dt. 30tI March 2022the Trading window for dealing in equity shares of the company is closed effective from 1st April 2022 and will remain closed till 26tr May 2022 pursuant to SEBI (PIT) Regulations 2015 and in terms of Code of Conduct to regulate monitor and report trading in securities of the Company. Request to take the above on record and acknowledge. Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2022, inter alia, has recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2021-22. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM. In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (May 24, 2022) had inter-alia: (i) Approved the Audited Financial Results for the quarter and year ended March 31, 2022, as recommended by the Audit Committee at its meeting held today (May 24 2022) The same along with the Independent Auditor's Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2021-22. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM. (As Per BSE Announcement Dated on 24.05.2022)
04-Feb-2022 11-Feb-2022 Quarterly Results AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 inter alia to consider and approve To consider and approve the Unaudited Financial Results for the quarter ended 31/12/2021 AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 ,inter alia, to consider and approve Please refer our earlier communication under reference about the Board Meeting. This is to further inform that in the Board Meeting to be held on Friday February 11th 2022 thru Video Conferencing, the Board will also consider declaration of Second Interim Dividend for the year 2021-22 With reference to the earlier letter dated February 04, 2022, about the Board Meeting, Amrutanjan Health Care Ltd has now informed BSE that the Board Meeting to be held on February 11, 2022 thru Video Conferencing, the Board will also consider declaration of Second Interim Dividend for the year 2021-22. (As Per BSE Announcement Dated on 07.02.2022) In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (February 11, 2022) had inter-alia: (i) Approved the Un-audited Financial Results for the quarter ended December 31, 2021. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Declared Second Interim Dividend of Re.1/- per share for the financial year 2021-22 on the Equity Shares of the Company. Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 11, 2022, inter alia, have declared Second Interim Dividend of Re.1/- per share for the financial year 2021-22 on the Equity Shares of the Company. Unaudited Financial Results for quarter ended 31/12/2021 (As Per BSE Announcement Dated 11.02.2022)
02-Nov-2021 09-Nov-2021 Quarterly Results Interim Dividend & Quarterly Results Amrutanjan Health Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 09 2021 inter alia has declared First Interim Dividend of Re. 1/- per share for the financial year 2021-22 on the Equity Shares of the Company. In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (November 09, 2021) had inter-alia: (i) Approved the Un-audited Financial Results for the quarter and half year ended September 30, 2021. The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Declared First Interim Dividend of Re.1/- per share for the financial year 2021-22 on the Equity Shares of the Company. (As Per BSE Announcement Dated on 11/9/2021 3:55:45 AM)
06-Aug-2021 14-Aug-2021 Quarterly Results AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 inter alia to consider and approve The Un-audited Financial Results for quarter ended June 30 2021 we wish to inform that the Board of Directors of the Company at its meeting held today (August 14, 2021) had inter-alia approved the 1. The Unaudited Financial Results for the quarter ended June 30, 2021 as recommended by the Audit Committee at its meeting held today (August 14, 2021).The same along with the Limited Review Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company, is enclosed Re-appointment of Director retiring by rotation (As Per BSE Announcement Dated 14.08.2021)
1 2